Sonoma Pharmaceuticals (SNOA) Net Margin Growth (3y) (2013 - 2025)
Sonoma Pharmaceuticals (SNOA) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,806.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -987.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 3,232.00 |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 4,703.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,703.00 |
| Sep 30, 2025 | 2,100.00 |
| Jun 30, 2025 | -864.00 |
| Sep 30, 2024 | -1,437.00 |
| Jun 30, 2024 | -390.00 |
| Dec 31, 2023 | -2,711.00 |
| Sep 30, 2023 | -5,380.00 |
| Jun 30, 2023 | -5,783.00 |
| Mar 31, 2023 | -4,370.00 |
| Dec 31, 2022 | -6,873.00 |
| Sep 30, 2022 | -3,233.00 |
| Jun 30, 2022 | -2,318.00 |
| Sep 30, 2021 | 5,021.00 |
| Jun 30, 2021 | 5,051.00 |
| Mar 31, 2020 | -374.00 |
| Dec 31, 2019 | -48,437.00 |
| Sep 30, 2019 | -2,501.00 |
| Jun 30, 2019 | -2,255.00 |
| Mar 31, 2019 | -9,006.00 |
| Dec 31, 2018 | -8,683.00 |